FDA’s Semaglutide Shortage Resolution: Legal Implications and Risks for Compounding Pharmacies
Massachusetts Senate Passes Bill to Increase Oversight of Private Equity Healthcare Transactions
OHCA Proposes Amendments to its Cost and Market Impact Review Program
California is Capping Health Care Cost Increases – Starting at 3.5% in 2025
CMS Issues CY2025 Medicare Advantage and Part D Final Rule
OIG Sparks Public Excitement about Managed Care and Alludes to Incoming Enforcement Guidance
OHCA Published Near-Final Draft of Regulations Requiring Notice and Review of Material Healthcare Transactions in 2024
CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule
